The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia.
about
Charting the molecular network of the drug target Bcr-AblCytokine Regulation of Microenvironmental Cells in Myeloproliferative NeoplasmsA potent and highly specific FN3 monobody inhibitor of the Abl SH2 domainTargeting the SH2-Kinase Interface in Bcr-Abl Inhibits LeukemogenesisSelective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.Further phenotypic characterization of the primitive lineage- CD34+CD38-CD90+CD45RA- hematopoietic stem cell/progenitor cell sub-population isolated from cord blood, mobilized peripheral blood and patients with chronic myelogenous leukemia.Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase InterfaceIncreased phosphorylation of eIF2α in chronic myeloid leukemia cells stimulates secretion of matrix modifying enzymes.Systems biology analysis of protein-drug interactions.Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms.Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia.TNF receptor p55 and IL-8(72) and IL-8(77) isoforms: blood and urine levels in breast cancer patients.TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy.
P2860
Q24317707-9D7AC9B1-97D2-412C-8903-453446111A40Q26778929-7D86DED0-8965-41ED-83B2-92B65D2442C7Q27660385-B5996133-F5A5-4332-8942-13C24873A712Q27675049-4B61E80C-C941-4055-8050-A6C32B07B9D3Q33637065-6DB0317E-62B3-4AB2-9270-D08F690778F7Q35664306-0E43DB24-C5C8-496B-BB9C-60A0C9020BC1Q36884733-7DAA9B41-FC21-414C-ADBB-E3675FED6ED9Q37694833-A5FE5F39-C26C-49BE-BE31-27EDE9724603Q37972867-C5A7E8C6-E61D-4E3E-BAC9-6FB1B9D618E1Q39121828-46C38486-1AB8-4D03-9EE6-70A926B7B42CQ40075528-9D01A8AE-9CD4-41C3-8FFF-45B21F9B0DBBQ43243529-7151A7D5-51C8-409A-BADE-092D08AC2CBDQ53206022-A39CFBA4-7208-4876-AB37-605E44BA0A62
P2860
The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The chemokine interleukin-8 an ...... y in chronic myeloid leukemia.
@en
type
label
The chemokine interleukin-8 an ...... y in chronic myeloid leukemia.
@en
prefLabel
The chemokine interleukin-8 an ...... y in chronic myeloid leukemia.
@en
P2860
P50
P1433
P1476
The chemokine interleukin-8 an ...... ty in chronic myeloid leukemia
@en
P2093
Agnes Gstoettenbauer
Ines Kaupe
P2860
P304
P356
10.1016/J.MOLONC.2008.07.003
P577
2008-07-23T00:00:00Z